- Clinical Trials
- January 2024
- 60 Pages
Global
From €1138EUR$1,250USD£975GBP
- Report
- June 2023
- 89 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Book
- August 2019
- 416 Pages
Dismutase is an enzyme that catalyzes the conversion of two molecules of a substrate into two different molecules. It is a type of oxidoreductase, which is an enzyme that catalyzes the transfer of electrons from one molecule to another. Dismutase is involved in a variety of metabolic processes, including the breakdown of toxic compounds, the production of energy, and the regulation of cell growth and differentiation. Dismutase is also used in the treatment of certain diseases, such as cancer and Alzheimer's disease.
The Dismutase market is composed of companies that produce and sell Dismutase enzymes for research and therapeutic applications. These companies offer a variety of products, including recombinant enzymes, purified enzymes, and enzyme-based kits. They also provide services such as custom enzyme production and enzyme-based assays.
Some companies in the Dismutase market include Abcam, Merck KGaA, Sigma-Aldrich, and Bio-Rad Laboratories. Show Less Read more